ACTIVE_NOT_RECRUITING

A Spanish-language Caregiver-Enabled Care Program

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to develop and test the feasibility of a nonmedical digital health intervention, the Spanish-language Caregiver-Enabled Care Program (CECP), with Spanish-speaking caregivers of persons with dementia (PWD). CECP is a nonmedical digital population health intervention that provides personalized education, proactive 1:1 human coaching, and remote monitoring, all delivered via a dedicated tablet shipped to the caregiver's home at no cost to the caregiver or PWD. For this study, the investigators are recruiting 135 patient/caregiver dyads.

Official Title

Improving Health Equities for Hispanic/Latino Families Living With Dementia by Validating a Spanish-language Caregiver-Enabled Care Program (CECP) in PACE Participants

Quick Facts

Study Start:2024-12-04
Study Completion:2026-02-27
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06631144

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Is a participant of a Program of All-Inclusive Care for the Elderly (PACE) or dementia support network or provider in the United States
  2. * Identifies as Hispanic/Latino
  3. * Has a Spanish-speaking familial caregiver (spouse, adult child, other family member, or friend) that is willing and able to participate in all aspects of this study
  4. * Has a diagnosis of dementia
  5. * Consents to participate in study, or has an Authorized Representative that consents
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Dirk Soenksen
PRINCIPAL_INVESTIGATOR
CEO

Study Locations (Sites)

Ceresti Health
Carlsbad, California, 92010
United States

Collaborators and Investigators

Sponsor: Ceresti Health, Inc.

  • Dirk Soenksen, PRINCIPAL_INVESTIGATOR, CEO

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-04
Study Completion Date2026-02-27

Study Record Updates

Study Start Date2024-12-04
Study Completion Date2026-02-27

Terms related to this study

Keywords Provided by Researchers

  • Digital Health Intervention
  • Spanish

Additional Relevant MeSH Terms

  • Dementia
  • Dementia Alzheimers
  • Alzheimer Disease
  • Caregiver
  • Caregiver Burden